Skip to main content
Log in

Effects of leukotrienes C4 and D4 on guinea-pig heart and the participation of SRS-A in the manifestations of guinea-pig cardiac anaphylaxis

  • Histamine and the Cardiovascular System
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

Synthetic leukotrienes C4 and D4 (LTC and LTD) were found to possess potent coronary vasoconstrictor and cardiac depressant actions on isolated guinea-pig hearts. We therefore went further to investigate the possibility that endogenously released slow-reacting substance of anaphylaxis (SRS-A) might be responsible for the coronary vasoconstriction and negative inotropism in guinea-pig cardiac anaphylaxis. Results using time-course analysis as well as the specific SRS antagonist FPL 55712 have shown that SRS-A released during cardiac anaphylaxis was unlikely to be responsible for the early and most dramatic phase of coronary vasoconstriction that usually occurred at the 2nd min after antigen challenge, but could possibly be responsible for the latter and more prolonged phase occurring between the 6th and 14th min. This is because SRS-A release was found to peak at the 4th min after antigen challenge, 2 min after vasoconstriction had already peaked. Moreover, this early component of coronary vasoconstriction could not be blocked by FPL 55712, whereas the latter component was significantly reduced by the antagonist.

The negative inotropism following cardiac anaphylaxis was also found to be significantly reduced by FPL 55712, thus suggesting SRS-A involvement. However, our experiments did not show whether the two actions were direct effects of SRS-A or whether contractility failure was a consequence of coronary vasoconstriction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. G.A. Feigen andD.J. Prager,Experimental cardiac anaphylaxis: Physiologic, pharmacologic and biochemical aspects of immune reactions in the isolated heart, Am. J. Cardiol.24, 474–491 (1969).

    Article  PubMed  Google Scholar 

  2. R. Levi,Effects of exogenous and immunologically released histamine on the isolated heart: A quantitative comparison, J. Pharmac. exp. Ther.182, 227–238 (1972).

    Google Scholar 

  3. R. Levi, J.H. Zavecz andZ. Ovary,IgE-mediated cardiac hypersensitivity reactions, Int. Archs Allergy appl. Immun.57, 529–534 (1978).

    Google Scholar 

  4. H. Anhut, W. Bernauer andB.A. Peskar,Radio-immunological determination of thromboxane release in cardiac anaphylaxis, Eur. J. Pharmac.44, 85–88 (1977).

    Article  Google Scholar 

  5. A. Giotti, A. Guidotti, P.F. Mannaioni andL. Zilletti,The influences of adrenotropic drugs and noradrenaline on the histamine release in cardiac anaphylaxis in vitro, J. Physiol., Lond.184, 924–941 (1966).

    Google Scholar 

  6. W.E. Brocklehurst,The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock, J. Physiol. Lond.151, 416–435 (1960).

    PubMed  Google Scholar 

  7. R. Liebig, W. Bernauer andB.A. Peskar,Prostaglandin, slow reacting substance and histamine release from anaphylactic guinea-pig hearts and its pharmacological modification, Naunyn-Schmiedebergs Arch. Pharmak. exp. Path.289, 65–76 (1975).

    Article  Google Scholar 

  8. G. Allan, J.H. Zavecz andR. Levi,Release of prostaglandins and SRS-A during cardiac anaphylaxis (Abs.), Bull. N.Y. Acad. Med.53, 304 (1977).

    Google Scholar 

  9. G. Allan andR. Levi,Thromoxane and prostacyclin release during cardiac immediate hypersensitivity reactions in vitro, J. Pharmac. exp. Ther.217, 157–161 (1981).

    Google Scholar 

  10. R.A. Lewis, K.F. Austen, J.M. Drazen, D.A. Clark, A. Marfat andE.J. Corey,Slow reacting substances of anaphylaxis: Identification of leukotrienes C-1 and D from human and rat sources, Proc. natn. Acad. Sci. USA77, 3710–3714 (1980).

    Google Scholar 

  11. Z. Terashita, H. Fukui, M. Hirata, S. Terao, S. Ohkawa, K. Nishikawa andS. Kikuchi,Coronary vasoconstriction and PGI 2 release by leukotrienes in isolated guinea-pig hearts, Eur. J. Pharmac.73, 357–361 (1981).

    Article  Google Scholar 

  12. L.G. Letts andP.J. Piper,The actions of leukotrienes C 4 and D 4 on guinea-pig isolated hearts, Br. J. Pharmac. Chemother.76, 169–176 (1982).

    Google Scholar 

  13. J.A. Burke, R. Levi, Z. Guo andE.J. Corey,Leukotrienes C 4,D 4 and E 4:Effects on human and guinea-pig cardiac preparations in vitro, J. Pharmac. exp. Ther.221, 235–241 (1982).

    Google Scholar 

  14. P.A. Shore, A. Burkhalter andV.H. Cohn,A method for the fluorometric assay of histamine in tissues, J. Pharmac. exp. Ther.127, 182–186 (1959).

    Google Scholar 

  15. J.P. Trzeciakowski andR. Levi Cardiac histamine: a mediator in search of a function, Trends in Pharmacological Sciences2, 14–17 (1981).

    Article  Google Scholar 

  16. H.J.L. Marriott, Coronary insufficiency and related matters. InPractical Electrocardiography, 5th ed., pp. 254–267 (Ed.H.J.L. Marriott) Baltimore 1974.

  17. H. Anhut, W. Bernauer andB.A. Peskar,Pharmacological modification of thromboxane and prostaglandin release in cardiac anaphylaxis, Prostaglandins15, 889–900 (1978).

    Article  PubMed  Google Scholar 

  18. G. Allan andR. Levi,The cardiac effects of prostaglandins and their modification by the prostaglandin antagonist N-0164, J. Pharmac. exp. Ther.214, 45–49 (1980).

    Google Scholar 

  19. E.F. Ellis, O. Oelz, L.J. Roberts, N.A. Payne, B.J. Sweetman, A.S. Nies andJ.A. Oates,Coronary arterial smooth muscle contraction by a substance release from platelets: Evidence that it is thromboxane A 2, Science193, 1135–1137 (1976).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ezeamuzie, I.C., Assem, E.S.K. Effects of leukotrienes C4 and D4 on guinea-pig heart and the participation of SRS-A in the manifestations of guinea-pig cardiac anaphylaxis. Agents and Actions 13, 182–187 (1983). https://doi.org/10.1007/BF01967327

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01967327

Keywords

Navigation